XML 43 R22.htm IDEA: XBRL DOCUMENT v3.21.1
RESTATEMENT OF PREVIOUSLY ISSUED FINANCIAL STATEMENTS (Tables)
11 Months Ended
Dec. 31, 2020
RESTATEMENT OF PREVIOUSLY ISSUED FINANCIAL STATEMENTS  
Schedule of restatement financial position

The impact of the restatement on the consolidated balance sheets, statements of operations and statements of cash flows for the Affected Periods is presented below.

 

 

 

 

 

 

 

 

 

 

 

 

 

    

As of December 31, 2020

 

Balance Sheet

 

As Previously
Reported

    

Restatement
Adjustment

    

As Restated

 

ASSETS

 

 

 

 

 

 

 

 

 

 

Current assets

 

 

 

 

 

 

 

 

 

 

Cash

 

$

158,599

 

 

 

$

158,599

 

Prepaid expenses

 

 

159,476

 

 

 

 

159,476

 

Total Current Assets

 

 

318,075

 

 

 

 

318,075

 

 

 

 

 

 

 

 

 

 

 

 

Cash and held to maturity securities held in Trust Account

 

 

414,333,909

 

 

 

 

414,333,909

 

Total Assets

 

$

414,651,984

 

 

 

$

414,651,984

 

 

 

 

 

 

 

 

 

 

 

 

LIABILITIES AND STOCKHOLDERS’ EQUITY

 

 

 

 

 

 

 

 

 

 

Current liabilities

 

 

 

 

 

 

 

 

 

 

Accounts payable and accrued expenses

 

$

2,789,052

 

 

 

$

2,789,052

 

Income taxes payable

 

 

14,632

 

 

 

 

14,632

 

Total Current Liabilities

 

 

2,803,684

 

 

 

 

2,803,684

 

 

 

 

 

 

 

 

 

 

 

 

Warrant liability

 

 

 

 

136,105,464

 

 

136,105,464

 

Deferred underwriting fee payable

 

 

14,490,000

 

 

 

 

14,490,000

 

Total Liabilities

 

 

17,293,684

 

 

136,105,464

 

 

153,399,148

 

 

 

 

 

 

 

 

 

 

 

 

Commitments and contingencies

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Class A common stock, $0.0001 par value, 25,625,283 shares subject to possible redemption at $10.00 per share

 

 

392,358,290

 

 

(136,105,460)

 

 

256,252,830

 

 

 

 

 

 

 

 

 

 

 

 

Stockholders’ Equity

 

 

 

 

 

 

 

 

 

 

Preferred stock, $0.0001 par value; 1,000,000 shares authorized; none issued or outstanding

 

 

 

 

 

 

 

Class A common stock, $0.0001 par value; 200,000,000 shares authorized; 15,774,717 issued and outstanding (excluding 25,625,283 shares subject to possible redemption)

 

 

216

 

 

1,361

 

 

1,577

 

Class B common stock, $0.0001 par value; 20,000,000 shares authorized; 10,350,000 shares issued and outstanding

 

 

1,035

 

 

 

 

1,035

 

Additional paid-in capital

 

 

8,453,607

 

 

128,748,555

 

 

137,202,162

 

Accumulated deficit

 

 

(3,454,848)

 

 

(128,749,920)

 

 

(132,204,768)

 

Total Stockholders’ Equity

 

 

5,000,010

 

 

(4)

 

 

5,000,006

 

Total Liabilities and Stockholders’ Equity

 

$

414,651,984

 

 

 

$

414,651,984

 

 

 

 

 

 

 

 

 

 

 

 

    

For the Period from February 4, 2020
(inception)
 through December 31, 2020

 

Statement of Operations

 

As Previously 
Reported

    

Restatement
Adjustment

    

As Restated

 

Loss from operations

 

 

(3,774,125)

 

 

(3,774,125)

 

 

 

 

 

 

 

 

 

 

Other income/ (expense):

 

 

 

 

 

 

 

 

Change in fair value of warrants

 

 

 

(128,463,731)

 

(128,463,731)

 

Transaction costs

 

 

 

(286,189)

 

(286,189)

 

Interest earned on marketable securities held in Trust Account

 

 

355,909

 

 

355,909

 

 

 

 

 

 

 

 

 

 

Loss before provision for income taxes

 

 

(3,418,216)

 

(128,749,920)

 

(132,168,136)

 

Provision for income taxes

 

 

(36,632)

 

 

(36,632)

 

 

 

 

 

 

 

 

 

 

Net loss

 

$

(3,454,848)

 

(128,749,920)

 

(132,204,768)

 

 

 

 

 

 

 

 

 

 

Weighted average shares outstanding of Class A redeemable common stock

 

 

40,948,182

 

 

40,948,182

 

Basic and diluted income per share, Class A redeemable common stock

 

$

 

 

 

 

 

 

 

 

 

 

 

 

Weighted average shares outstanding of Class B non-redeemable common stock(1)

 

 

9,839,969

 

 

9,839,969

 

Basic and diluted net loss per share, Class B non-redeemable common stock

 

$

(0.37)

 

(13.08)

 

(13.45)

 

 

 

 

 

 

 

 

 

 

 

 

    

For the Period from February 4, 2020
(inception)
 through December 31, 2020

 

Statement of Cash Flows

 

As Previously
Reported

    

Restatement
Adjustment

    

As Restated

 

 

 

 

 

 

 

 

 

 

Net loss

 

$

(3,454,848)

 

(128,749,920)

 

(132,204,768)

 

Adjustments to reconcile net loss to net cash used in operating activities:

 

 

 

 

 

 

 

 

Change in fair value of warrants

 

 

 

128, 463,731

 

128, 463,731

 

Transaction costs allocated to warrant liability

 

 

 

286,189

 

286,189

 

Net cash used in operating activities

 

 

(1,166,549)

 

 

(1,166,549)

 

Net cash used in investing activities

 

 

(413,978,000)

 

 

(413,978,000)

 

Net cash provided by financing activities

 

 

415,303,148

 

 

415,303,148

 

 

 

 

 

 

 

 

 

 

 

 

 

    

As of September 30, 2020

 

Unaudited Balance Sheet

    

As Previously
Reported

    

Restatement
Adjustment

    

As Restated

 

ASSETS

 

 

 

 

 

 

 

Current assets

 

 

 

 

 

 

 

 

 

Cash

 

$

759,102 

 

 

$

759,102 

 

Prepaid expenses

 

 

240,602 

 

 

 

240,602 

 

Total Current Assets

 

 

999,704 

 

 

 

999,704 

 

 

 

 

 

 

 

 

 

 

 

Cash and held to maturity securities held in Trust Account

 

 

414,222,151 

 

 —

 

 

414,222,151 

 

Total Assets

 

$

415,221,855 

 

 —

 

$

415,221,855 

 

 

 

 

 

 

 

 

 

 

 

LIABILITIES AND STOCKHOLDERS’ EQUITY

 

 

 

 

 

 

 

 

 

Current liabilities

 

 

 

 

 

 

 

 

 

Accounts payable and accrued expenses

 

$

280,690 

 

 —

 

$

280,690 

 

Income taxes payable

 

 

29,152 

 

 —

 

 

29,152 

 

Total Current Liabilities

 

 

309,842 

 

 —

 

 

309,842 

 

 

 

 

 

 

 

 

 

 

 

Warrant liability

 

 

 

20,033,733 

 

 

20,033,733 

 

Deferred underwriting fee payable

 

 

14,490,000 

 

 —

 

 

14,490,000 

 

Total Liabilities

 

 

14,799,842 

 

20,033,733

 

 

34,833,575 

 

 

 

 

 

 

 

 

 

 

 

Commitments and contingencies

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Class A common stock, $0.0001 par value, 37,538,827 shares subject to possible redemption at $10.00 per share

 

 

395,422,010 

 

(20,033,740)

 

 

375,388,270 

 

 

 

 

 

 

 

 

 

 

 

Stockholders’ Equity

 

 

 

 

 

 

 

 

 

Preferred stock, $0.0001 par value; 1,000,000 shares authorized; none issued or outstanding

 

 

 

 

 

 

Class A common stock, $0.0001 par value; 200,000,000 shares authorized; 3,861,173 issued and outstanding (excluding 37,538,827 shares subject to possible redemption)

 

 

186 

 

 

 

186 

 

Class B common stock, $0.0001 par value; 20,000,000 shares authorized; 10,350,000 shares issued and outstanding

 

 

1,035 

 

 

 

1,035 

 

Additional paid-in capital

 

 

5,389,917 

 

12,678,196 

 

 

18,068,113 

 

Accumulated deficit

 

 

(391,135)

 

(12,678,189)

 

 

(13,069,324)

 

Total Stockholders’ Equity

 

 

5,000,003 

 

 

 

5,000,010 

 

Total Liabilities and Stockholders’ Equity

 

$

415,221,855 

 

 

$

415,221,855 

 

 

 

 

For the Three Months Ended September 30, 2020

 

Unaudited Statement of Operations

    

As Previously
Reported

    

Restatement
Adjustment

    

As Restated

 

Loss from operations

 

$

(462,905)

 

 

 

$

(462,905)

 

 

 

 

 

 

 

 

 

 

 

 

Other income/ (expense):

 

 

 

 

 

 

 

 

 

 

Change in fair value of warrants

 

 

 

 

(7,848,267)

 

 

(7,848,267)

 

Interest earned on marketable securities held in Trust Account

 

 

165,021 

 

 

 

 

165,021 

 

 

 

 

 

 

 

 

 

 

 

 

Loss before provision for income taxes

 

 

(297,884)

 

 

(7,848,267)

 

 

(8,146,151)

 

Provision for income taxes

 

 

(29,152)

 

 

 

 

(29,152)

 

 

 

 

 

 

 

 

 

 

 

 

Net loss

 

$

(327,036)

 

$

(7,848,267)

 

$

(8,175,303)

 

 

 

 

 

 

 

 

 

 

 

 

Weighted average shares outstanding of Class A redeemable common stock

 

 

41,400,000 

 

 

 —

 

 

41,400,000 

 

Basic and diluted income per share, Class A redeemable common stock

 

$

 

 

 —

 

 

— 

 

 

 

 

 

 

 

 

 

 

 

 

Weighted average shares outstanding of Class B non-redeemable common stock(1)

 

 

10,350,000 

 

 

 —

 

 

10,350,000 

 

Basic and diluted net loss per share, Class B non-redeemable common stock

 

$

(0.03)

 

$

(0.77)

 

$

(0.80)

 

 

 

 

For the Period from February 4, 2020 (inception)
through September 30, 2020

 

Unaudited Statement of Operations

    

As Previously
Reported

    

Restatement
Adjustment

    

As Restated

 

Loss from operations

 

$

(584,134)

 

$

 

$

(584,134)

 

 

 

 

 

 

 

 

 

 

 

 

Other income/ (expense):

 

 

 

 

 

 

 

 

 

 

Change in fair value of warrants

 

 

 

 

(12,392,000)

 

 

(12,392,000)

 

Transaction costs

 

 

 

 

(286,189)

 

 

(286,189)

 

Interest earned on marketable securities held in Trust Account

 

 

222,151 

 

 

 

 

222,151 

 

 

 

 

 

 

 

 

 

 

 

 

Loss before provision for income taxes

 

 

(361,983)

 

 

(12,678,189)

 

 

(13,040,172)

 

Provision for income taxes

 

 

(29,152)

 

 

 

 

(29,152)

 

 

 

 

 

 

 

 

 

 

 

 

Net loss

 

$

(391,135)

 

$

(12,678,189)

 

$

(13,069,324)

 

 

 

 

 

 

 

 

 

 

 

 

Weighted average shares outstanding of Class A redeemable common stock

 

 

40,617,323 

 

 

 —

 

 

40,617,323 

 

Basic and diluted income per share, Class A redeemable common stock

 

$

— 

 

 

 —

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Weighted average shares outstanding of Class B non-redeemable common stock(1)

 

 

10,350,000 

 

 

 —

 

 

10,350,000 

 

Basic and diluted net loss per share, Class B non-redeemable common stock

 

$

(0.04)

 

$

(1.23)

 

 

(1.27)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

For the Period from February 4, 2020 (inception)
through September 30, 2020

 

Unaudited Statement of Cash Flows

    

As Previously
Reported

    

Restatement
Adjustment

    

As Restated

 

 

 

 

 

 

 

 

 

 

 

 

Net loss

 

$

(391,135)

 

 

(12,678,189)

 

 

(132,069,324)

 

Adjustments to reconcile net loss to net cash used in operating activities:

 

 

 

 

 

 

 

 

 

 

Change in fair value of warrants

 

 

 

 

12, 392,000

 

 

12, 392,000

 

Transaction costs allocated to warrant liability

 

 

 

 

286,189

 

 

286,189

 

Net cash used in operating activities

 

 

(544,046)

 

 

 

 

(544,046)

 

Net cash used in investing activities

 

 

(414,000,000)

 

 

 

 

(414,000,000)

 

Net cash provided by financing activities

 

 

415,303,148 

 

 

 

 

415,303,148 

 

 

 

 

As of June 30, 2020

 

Unaudited Balance Sheet

    

As Previously
Reported

    

Restatement
Adjustment

    

As Restated

 

ASSETS

 

 

 

 

 

 

 

 

 

 

Current assets

 

 

 

 

 

 

 

 

 

 

Cash

 

$

909,187

 

$

 

$

909,187

 

Prepaid expenses

 

 

340,399

 

 

 

 

340,399

 

Total Current Assets

 

 

1,249,586

 

 

 

 

1,249,586

 

 

 

 

 

 

 

 

 

 

 

 

Cash and held to maturity securities held in Trust Account

 

 

414,057,130

 

 

 

 

414,057,130

 

Total Assets

 

$

415,306,716

 

 

 

$

415,306,716

 

 

 

 

 

 

 

 

 

 

 

 

LIABILITIES AND STOCKHOLDERS’ EQUITY

 

 

 

 

 

 

 

 

 

 

Current liabilities

 

 

 

 

 

 

 

 

 

 

Accounts payable and accrued expenses

 

$

67,667

 

 

 

$

67,667

 

Income taxes payable

 

 

 

 

 

 

 

Total Current Liabilities

 

 

67,667

 

 

 

 

67,667

 

 

 

 

 

 

 

 

 

 

 

 

Warrant liability

 

 

 

 

12,185,466

 

 

12,185,466

 

Deferred underwriting fee payable

 

 

14,490,000

 

 

 

 

14,490,000

 

Total Liabilities

 

 

14,557,667

 

 

12,185,466

 

 

26,743,133

 

 

 

 

 

 

 

 

 

 

 

 

Commitments and contingencies

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Class A common stock, $0.0001 par value, subject to possible redemption, 38,356,358 shares at $10.00 per share

 

 

395,749,040

 

 

(12,185,460)

 

 

383,563,580

 

 

 

 

 

 

 

 

 

 

 

 

Stockholders’ Equity

 

 

 

 

 

 

 

 

 

 

Preferred stock, $0.0001 par value; 1,000,000 shares authorized; none issued or outstanding

 

 

 

 

 

 

 

Class A common stock, $0.0001 par value; 200,000,000 shares authourized; 3,043,642 issued or outstanding (excluding 38,356,325 shares subject to possible redemption)

 

 

183

 

 

 

 

183

 

Class B common stock, $0.0001 par value; 20,000,000 shares authourized; 10,350,000 issued or outstanding

 

 

1,035

 

 

 

 

1,035

 

Additional paid-in capital

 

 

5,062,890

 

 

4,829,917

 

 

9,892,807

 

Accumulated deficit

 

 

(64,099)

 

 

(4,829,923)

 

 

(4,894,022)

 

Total Stockholders’ Equity

 

 

5,000,009

 

 

(6)

 

 

5,000,003

 

Total Liabilities and Stockholders’ Equity

 

$

415,306,716

 

$

 

$

415,306,716

 

 

 

 

 

For the Three Months Ended June 30, 2020

 

 

    

As Previously
Reported

    

Restatement
Adjustment

    

As Restated

 

Unaudited Statement of Operations

 

 

 

 

 

 

 

 

 

 

Loss from operations

 

$

(120,229)

 

$

 

$

(120,229)

 

 

 

 

 

 

 

 

 

 

 

 

Other income/ (expense):

 

 

 

 

 

 

 

 

 

 

Change in fair value of warrants

 

 

 

 

(4,543,733)

 

 

(4,543,733)

 

Transaction costs

 

 

 

 

(286,189)

 

 

(286,189)

 

Interest earned on marketable securities held in Trust Account

 

 

57,130

 

 

 

 

57,130

 

 

 

 

 

 

 

 

 

 

 

 

Loss before provision for income taxes

 

 

(63,099)

 

 

(4,829,922)

 

 

(4,893,021)

 

Provision for income taxes

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Net loss

 

$

(63,099)

 

$

(4,829,922)

 

$

(4,893,021)

 

 

 

 

 

 

 

 

 

 

 

 

Weighted average shares outstanding of Class A redeemable common stock

 

 

38,560,000

 

 

 

 

38,560,000

 

Basic and diluted income per share, Class A redeemable common stock

 

$

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Weighted average shares outstanding of Class B non-redeemable common stock(1)

 

 

10,350,000

 

 

 

 

10,350,000

 

Basic and diluted net loss per share, Class B non-redeemable common stock

 

$

(0.01)

 

$

(0.47)

 

$

(0.48)

 

 

 

 

For the Period from February 4, 2020
(inception) through June 30, 2020

 

 

    

As Previously Reported

    

Restatement
Adjustment

    

As Restated

 

Unaudited Statement of Operations Loss from operations

 

$

(121,229)

 

$

 

$

(121,229)

 

 

 

 

 

 

 

 

 

 

 

 

Other income/ (expense):

 

 

 

 

 

 

 

 

 

 

Change in fair value of warrants

 

 

 

 

(4,543,733)

 

 

(4,543,733)

 

Transaction costs

 

 

 

 

(286,189)

 

 

(286,189)

 

Interest earned on marketable securities held in Trust Account

 

 

57,130

 

 

 

 

57,130

 

 

 

 

 

 

 

 

 

 

 

 

Loss before provision for income taxes

 

 

(64,099)

 

 

(4,829,922)

 

 

(4,894,021)

 

Provision for income taxes

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Net loss

 

$

(64,099)

 

$

(4,829,922)

 

$

(4,894,021)

 

 

 

 

 

 

 

 

 

 

 

 

Weighted average shares outstanding of Class A redeemable common stock

 

 

38,560,000

 

 

 

 

38,560,000

 

Basic and diluted income per share, Class A redeemable common stock

 

$

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Weighted average shares outstanding of Class B non-redeemable common stock

 

 

10,350,000

 

 

 

 

10,350,000

 

Basic and diluted net loss per share, Class B non-redeemable common stock

 

$

(0.01)

 

$

(0.47)

 

$

(0.48)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

For the Period from February 4, 2020 (inception)
through June 30, 2020

 

Unaudited Statement of Cash Flows

    

As Previously
Reported

    

Restatement
Adjustment

    

As Restated

 

 

 

 

 

 

 

 

 

 

 

 

Net loss

 

$

(64,099)

 

 

(4,829,922)

 

 

(4,894,021)

 

Adjustments to reconcile net loss to net cash used in operating activities:

 

 

 

 

 

 

 

 

 

 

Change in fair value of warrants

 

 

 

 

4, 543,733

 

 

4, 543,733

 

Transaction costs allocated to warrant liability

 

 

 

 

286,189

 

 

286,189

 

Net cash used in operating activities

 

 

(393,961)

 

 

 

 

(393,961)

 

Net cash used in investing activities

 

 

(414,000,000)

 

 

 

 

(414,000,000)

 

Net cash provided by financing activities

 

 

415,303,148

 

 

 

 

415,303,148